Succeeding in the New World of Healthcare

whitePaper | June 16, 2022

Study feasibility is a fundamental contributor to the overall success of a clinical development program. However, selecting the right countries, sites and investigators and starting

whitePaper | April 7, 2022

For more than 30 years, the NuSil™ brand has been continuously supplying medical device manufacturers with silicones of the highest purity and long-term stability for medical implant applications.

whitePaper | March 4, 2020

Health leaders must understand the benefits of their investments in performance improvement projects and the impact on the organization. The traditional approach is most often to measure ROI (return on investment) and, while clearly measurable, is most often related to cost savings or increased revenue and can leave you with an incomplete story. Incorporating VOI (value on investment) enables you to quantify the intangible benefits of your projects and activities making the combination of the two a more robust indicator of project success.

whitePaper | December 20, 2022

During the COVID-19 pandemic, drug overdose deaths have increased. At the same time, access to and utilization of substance use disorder treatment services have decreased.

whitePaper | June 24, 2023

A first-in-human (FIH) clinical trial is a significant milestone in the development of a potential new drug in that it will be the first opportunity for a drug development sponsor to evaluate the impact of their new chemical entity (NCE) or biologic in humans.

whitePaper | January 9, 2020

Radiation therapy is one of the most common treatments used to fight cancer in the U.S., with more than half of cancer patients receiving it either alone or in combination with other medical interventions.1 With the traditional approach to radiation therapy, the dose and schedule is tailored to the tumor type, location, and stage of growth, but only infrequently updated in light of changes after treatment starts. Experts in adaptive therapy are looking to deliver a more personalized treatment strategy guided by the individual patient’s needs.